Abstract
Pregnancy should have a successful outcome in a patient with treated Wilson's disease if complications are excluded before conception. Chelating treatment must be maintained, although there is some concern about its teratogenicity. We describe the course of pregnancy in a patient with Wilson's disease treated with D-penicillamine and zinc sulfate.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adult
-
Chelating Agents / adverse effects
-
Chelating Agents / therapeutic use
-
Female
-
Foot Deformities, Congenital / chemically induced
-
Hepatolenticular Degeneration / drug therapy*
-
Humans
-
Infant, Newborn
-
Penicillamine / adverse effects
-
Penicillamine / therapeutic use
-
Pregnancy
-
Pregnancy Complications / drug therapy*
-
Zinc Sulfate / adverse effects
-
Zinc Sulfate / therapeutic use
Substances
-
Chelating Agents
-
Zinc Sulfate
-
Penicillamine